Literature DB >> 10758256

Obsessive-compulsive disorder in schizophrenia.

P Tibbo1, M Kroetsch, P Chue, L Warneke.   

Abstract

OBJECTIVE: To examine the differences in demographic and clinical features of patients with schizophrenia, with or without comorbid obsessive-compulsive disorder (OCD).
METHODS: Fifty-two subjects were recruited from clinical services in the city of Edmonton, Alberta and assessed for schizophrenia and OCD with structured clinical interviews and standardized clinical rating scales.
RESULTS: The prevalence of OCD in individuals meeting criteria for schizophrenia was 25%. Those subjects having both schizophrenia and OCD scored significantly higher on the Y-BOCS, Hollingshead scale, and GAF; plus significantly lower PANSS negative symptoms and a trend in increased Parkinsonian symptoms compared with individuals with schizophrenia alone.
CONCLUSION: Our preliminary findings indicate that patients with schizophrenia and OCD vary in selected demographic and clinical measures when compared to patients with schizophrenia alone. Patients with schizophrenia and OCD appear to have less negative symptoms, which may thus be reflected in the decreased GAF scores. It is speculated that patients with schizophrenia and OCD may have a greater propensity to basal ganglia dysfunction than those with schizophrenia alone resulting in increased Parkinsonian symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 10758256     DOI: 10.1016/s0022-3956(99)00048-5

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  25 in total

1.  Co-morbid anxiety disorders in patients with schizophrenia in a tertiary institution in South East Nigeria: prevalence and correlates.

Authors:  Chinyere Aguocha; Kelechi Aguocha; Richard Uwakwe; Gabriel Onyeama
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

2.  Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment.

Authors:  Yuki Adam; Gunther Meinlschmidt; Andrew T Gloster; Roselind Lieb
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-02       Impact factor: 4.328

Review 3.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

4.  Interventions for obsessive compulsive symptoms in people with schizophrenia.

Authors:  Mohan Raj; Saeed Farooq
Journal:  Cochrane Database Syst Rev       Date:  2005

5.  Dissociation between MEG alpha modulation and performance accuracy on visual working memory task in obsessive compulsive disorder.

Authors:  Kristina T Ciesielski; Matti S Hämäläinen; Daniel A Geller; Sabine Wilhelm; Timothy E Goldsmith; Seppo P Ahlfors
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

6.  Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia.

Authors:  Natasha Radhu; Luis Garcia Dominguez; Faranak Farzan; Margaret A Richter; Mawahib O Semeralul; Robert Chen; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Brain       Date:  2014-12-17       Impact factor: 13.501

Review 7.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

8.  Prevalence of obsessive compulsive symptoms among patients with schizophrenia.

Authors:  Smita Hemrom; Divya Prasad; Masroor Jahan; Amool R Singh; D K Kenswar
Journal:  Ind Psychiatry J       Date:  2009-07

9.  Obsessive compulsive symptoms in the psychosis prodrome: correlates of clinical and functional outcome.

Authors:  Tara A Niendam; Jodi Berzak; Tyrone D Cannon; Carrie E Bearden
Journal:  Schizophr Res       Date:  2008-12-20       Impact factor: 4.939

Review 10.  Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation.

Authors:  Susan R McGurk; Kim T Mueser; Thomas J DeRosa; Rosemarie Wolfe
Journal:  Schizophr Bull       Date:  2009-03-05       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.